We are live on
!
Find out more
TCM
Timpani Capital Management Portfolio holdings
AUM
$209M
1-Year Est. Return
62.15%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+62.15%
3 Year Est. Return
+383.19%
5 Year Est. Return
+934.71%
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$4.01M
(-1.8%)
Cap. Flow
+$405K
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
106
New
26
Increased
35
Reduced
24
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNT
Verint Systems
VRNT
|
+$3.72M |
| 2 |
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
|
+$3.63M |
| 3 |
AKRX
Akorn Inc
AKRX
|
+$3.15M |
| 4 |
EXAM
EXAMWORKS GROUP INC COM STK (DE)
EXAM
|
+$3.11M |
| 5 |
Enphase Energy
ENPH
|
+$3.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marchex
MCHX
|
+$5.91M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$3.66M |
| 3 |
FINL
Finish Line
FINL
|
+$3.13M |
| 4 |
PRFT
Perficient Inc
PRFT
|
+$3.07M |
| 5 |
SWFT
Swift Transportation Company
SWFT
|
+$2.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 16.71% |
| 3 | Consumer Discretionary | 16.65% |
| 4 | Industrials | 12.33% |
| 5 | Energy | 8.83% |
Similar funds
UIM
CI
CWM
BA
TAM
HAM
EMR
NAP
Timpani Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Timpani Capital Management held 106 positions worth $219M, down 1.8% from $223M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Timpani Capital Management's Q3 2014 filing shows 26 new, 35 increased, 24 reduced and 21 closed positions. Its largest new stake was Verint Systems: 145,331 shares worth $4.12M. The largest sale was Marchex, an estimated $5.91M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Timpani Capital Management's largest Q3 2014 buy was Verint Systems: 145,331 shares worth $4.12M.
- Timpani Capital Management added most to Proofpoint, Inc. in Q3 2014, an estimated $3M increase.
- Timpani Capital Management's biggest Q3 2014 reduction was Ligand Pharmaceuticals, cutting an estimated $3.66M.
- Timpani Capital Management fully exited Marchex in Q3 2014, selling an estimated $5.91M.
- Timpani Capital Management's ten largest holdings make up 27% of its $219M portfolio in Q3 2014.
- Timpani Capital Management opened 26 new positions and closed 21 in Q3 2014.
- Timpani Capital Management's portfolio value fell 1.8% quarter-over-quarter to $219M.
Based on Timpani Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.